Analysts Adjust Ratings Amid Market Downturn
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy GMED?
Source: Benzinga
Globus Medical Inc. saw a price decline of 3.31% as it hit a 20-day low amid a broader market downturn, with the Nasdaq-100 down 2.16% and the S&P 500 down 1.44%.
The recent adjustments in analyst ratings reflect a shift in market sentiment, prompting investors to reassess their portfolios. While specific ratings for Globus Medical were not mentioned, the overall trend indicates a cautious approach from analysts, which could influence investor decisions in the current market environment.
This decline in stock price highlights the challenges faced by Globus Medical in a tough market, and investors may need to consider these analyst insights as they navigate their investment strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GMED?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GMED
Wall Street analysts forecast GMED stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GMED is 101.00 USD with a low forecast of 87.00 USD and a high forecast of 114.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
9 Buy
4 Hold
0 Sell
Moderate Buy
Current: 87.500
Low
87.00
Averages
101.00
High
114.00
Current: 87.500
Low
87.00
Averages
101.00
High
114.00
About GMED
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery techniques. It includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Wall Street Analysts Adjust Ratings
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, reflecting a shift in market sentiment that could influence investor decisions and market trends.
- Overview of Changes: The rating changes include upgrades, downgrades, and new initiations, showcasing analysts' responsiveness to market dynamics, which may prompt investors to reassess their portfolios.
- Investor Focus: For those considering buying LUV stock, analysts' perspectives will serve as a crucial reference, impacting their timing and strategy, potentially affecting the stock's short-term performance.
- Market Information Source: This information is provided by Benzinga, highlighting the significance of analyst ratings in investment decisions, urging investors to monitor these changes to optimize their investment strategies.
See More
Bone Grafts Market Report: Forecast to 2036
- Market Size Forecast: The report indicates significant growth in the bone grafts and substitutes market projected by 2036, with detailed intervention volumes and market value data across 39 countries aiding strategic decision-making for businesses.
- Product Segmentation Analysis: It provides an in-depth analysis of various bone graft substitutes, including allograft bone chips and bone morphogenetic proteins, offering insights into market share and average selling prices to help companies optimize their product portfolios.
- Competitive Dynamics Insights: Through SWOT analysis and exploration of competitive dynamics, the report reveals the market positions of key players such as Medtronic and Stryker, assisting investors in identifying potential investment opportunities.
- Market Access Strategies: Additionally, the report offers detailed information on market access, including reimbursement policies and regulatory landscapes, enabling companies to formulate effective market entry strategies in a complex environment.
See More
Globus Medical CFO Kyle Kline Sells 3,594 Shares
- Executive Sell-off: On January 8, 2026, Globus Medical's CFO Kyle Kline sold 3,594 shares, which may raise concerns about the company's future performance, as executive sell-offs are often perceived as negative signals regarding company outlook.
- Market Reaction: While the specific sale price was not disclosed, executive stock transactions can significantly impact investor confidence, potentially leading to short-term stock price volatility, prompting investors to closely monitor subsequent market developments.
- Governance Concerns: Such executive sell-offs may trigger scrutiny of the company's governance structure, particularly regarding transparency and executive stock incentives, possibly prompting the company to enhance internal governance measures to maintain investor trust.
- Investor Strategy Adjustment: Investors may reassess their investment strategies in Globus Medical based on this news, especially in the current market environment, necessitating caution regarding the potential risks associated with executive sell-offs.
See More
US Stocks Close Mixed on Thursday as Tech Sector Faces Pressure
- Market Volatility: The S&P 500 Index closed up 0.01% while the Dow Jones Industrial Average rose 0.55%, and the Nasdaq 100 fell 0.57%, indicating mixed market performance amid weakness in tech stocks.
- Economic Data Impact: Initial jobless claims in the US rose by 8,000 to 208,000, lower than the expected 212,000, suggesting a strong labor market that could influence Fed policy in a hawkish direction.
- Military Spending Expectations: President Trump announced plans to increase the US military budget by 50% to $1.5 trillion by 2027, leading to a rally in defense stocks, with AeroVironment rising over 8%.
- Energy Market Rebound: Energy producers surged as WTI crude oil prices rose by more than 3%, with APA Corp leading gains in the S&P 500, up over 8%.
See More
Trump Plans to Increase Military Spending to $1.5 Trillion
- Military Budget Increase: President Trump plans to ramp up U.S. military spending by about 50% to $1.5 trillion by 2027, which is expected to significantly boost growth in the defense sector and enhance market confidence in related companies.
- Defense Stocks Rally: Following this announcement, AeroVironment (AVAV) shares surged over 8%, and Huntington Ingalls Industries (HII) rose more than 7%, reflecting investor optimism regarding increased defense spending.
- Market Reaction: Despite weakness in chipmakers and software companies, the strong performance of defense stocks helped contain broader market declines, indicating a divergence in capital flows and investor sentiment across sectors.
- Economic Data Impact: U.S. economic data showed initial jobless claims rose to 208,000, lower than the expected 212,000, suggesting a robust labor market that could influence the Federal Reserve's monetary policy direction.
See More
Trump Plans to Increase Military Spending to $1.5 Trillion
- Military Budget Increase: President Trump plans to raise U.S. military spending by approximately 50% to $1.5 trillion by 2027, which is expected to significantly boost growth in the defense sector and enhance the market performance of related companies.
- Defense Stocks Surge: Following this announcement, Northrop Grumman (NOC) shares rose over 10% and Lockheed Martin (LMT) increased by more than 8%, indicating a positive market reaction to increased defense spending that may attract more investor interest in the sector.
- Supportive Economic Data: U.S. December Challenger job cuts fell 8.3% year-on-year to 35,553, marking a 17-month low, which reflects a strong labor market and provides a favorable economic backdrop for increased defense spending, potentially influencing Federal Reserve policy.
- Market Reaction: While the broader stock market faced pressure from profit-taking in chipmakers and software firms, the robust performance of defense stocks demonstrates optimistic market expectations regarding Trump's policies, which may drive future investment and growth in the industry.
See More
Wall Street Analysts Adjust Ratings
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, reflecting a shift in market sentiment that could influence investor decisions and market trends.
- Overview of Changes: The rating changes include upgrades, downgrades, and new initiations, showcasing analysts' responsiveness to market dynamics, which may prompt investors to reassess their portfolios.
- Investor Focus: For those considering buying LUV stock, analysts' perspectives will serve as a crucial reference, impacting their timing and strategy, potentially affecting the stock's short-term performance.
- Market Information Source: This information is provided by Benzinga, highlighting the significance of analyst ratings in investment decisions, urging investors to monitor these changes to optimize their investment strategies.
See More
Bone Grafts Market Report: Forecast to 2036
- Market Size Forecast: The report indicates significant growth in the bone grafts and substitutes market projected by 2036, with detailed intervention volumes and market value data across 39 countries aiding strategic decision-making for businesses.
- Product Segmentation Analysis: It provides an in-depth analysis of various bone graft substitutes, including allograft bone chips and bone morphogenetic proteins, offering insights into market share and average selling prices to help companies optimize their product portfolios.
- Competitive Dynamics Insights: Through SWOT analysis and exploration of competitive dynamics, the report reveals the market positions of key players such as Medtronic and Stryker, assisting investors in identifying potential investment opportunities.
- Market Access Strategies: Additionally, the report offers detailed information on market access, including reimbursement policies and regulatory landscapes, enabling companies to formulate effective market entry strategies in a complex environment.
See More
Globus Medical CFO Kyle Kline Sells 3,594 Shares
- Executive Sell-off: On January 8, 2026, Globus Medical's CFO Kyle Kline sold 3,594 shares, which may raise concerns about the company's future performance, as executive sell-offs are often perceived as negative signals regarding company outlook.
- Market Reaction: While the specific sale price was not disclosed, executive stock transactions can significantly impact investor confidence, potentially leading to short-term stock price volatility, prompting investors to closely monitor subsequent market developments.
- Governance Concerns: Such executive sell-offs may trigger scrutiny of the company's governance structure, particularly regarding transparency and executive stock incentives, possibly prompting the company to enhance internal governance measures to maintain investor trust.
- Investor Strategy Adjustment: Investors may reassess their investment strategies in Globus Medical based on this news, especially in the current market environment, necessitating caution regarding the potential risks associated with executive sell-offs.
See More
US Stocks Close Mixed on Thursday as Tech Sector Faces Pressure
- Market Volatility: The S&P 500 Index closed up 0.01% while the Dow Jones Industrial Average rose 0.55%, and the Nasdaq 100 fell 0.57%, indicating mixed market performance amid weakness in tech stocks.
- Economic Data Impact: Initial jobless claims in the US rose by 8,000 to 208,000, lower than the expected 212,000, suggesting a strong labor market that could influence Fed policy in a hawkish direction.
- Military Spending Expectations: President Trump announced plans to increase the US military budget by 50% to $1.5 trillion by 2027, leading to a rally in defense stocks, with AeroVironment rising over 8%.
- Energy Market Rebound: Energy producers surged as WTI crude oil prices rose by more than 3%, with APA Corp leading gains in the S&P 500, up over 8%.
See More
Trump Plans to Increase Military Spending to $1.5 Trillion
- Military Budget Increase: President Trump plans to ramp up U.S. military spending by about 50% to $1.5 trillion by 2027, which is expected to significantly boost growth in the defense sector and enhance market confidence in related companies.
- Defense Stocks Rally: Following this announcement, AeroVironment (AVAV) shares surged over 8%, and Huntington Ingalls Industries (HII) rose more than 7%, reflecting investor optimism regarding increased defense spending.
- Market Reaction: Despite weakness in chipmakers and software companies, the strong performance of defense stocks helped contain broader market declines, indicating a divergence in capital flows and investor sentiment across sectors.
- Economic Data Impact: U.S. economic data showed initial jobless claims rose to 208,000, lower than the expected 212,000, suggesting a robust labor market that could influence the Federal Reserve's monetary policy direction.
See More
Trump Plans to Increase Military Spending to $1.5 Trillion
- Military Budget Increase: President Trump plans to raise U.S. military spending by approximately 50% to $1.5 trillion by 2027, which is expected to significantly boost growth in the defense sector and enhance the market performance of related companies.
- Defense Stocks Surge: Following this announcement, Northrop Grumman (NOC) shares rose over 10% and Lockheed Martin (LMT) increased by more than 8%, indicating a positive market reaction to increased defense spending that may attract more investor interest in the sector.
- Supportive Economic Data: U.S. December Challenger job cuts fell 8.3% year-on-year to 35,553, marking a 17-month low, which reflects a strong labor market and provides a favorable economic backdrop for increased defense spending, potentially influencing Federal Reserve policy.
- Market Reaction: While the broader stock market faced pressure from profit-taking in chipmakers and software firms, the robust performance of defense stocks demonstrates optimistic market expectations regarding Trump's policies, which may drive future investment and growth in the industry.
See More
